Nvidia scrutiny continues as smaller AI startups assess risks
The fallout from scrutiny surrounding Nvidia is being watched by smaller artificial intelligence companies that operate farther down the technology supply chain. Michal Miernowski, co-founder and CEO of Amperos Health, said his company, which develops AI agents for healthcare billing, is separated from Nvidia by roughly two layers of applied AI activity. He does not expect the company to be affected directly because it uses both leading AI models and open-source systems.